Summit Therapeutics, Inc. (SMMT)
17.94
+0.92
(+5.41%)
USD |
NASDAQ |
Dec 10, 16:00
17.90
-0.04
(-0.22%)
After-Hours: 20:00
Summit Therapeutics EPS Diluted (Quarterly): -0.3118 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| CVS Health Corp. | -3.132 |
| UnitedHealth Group, Inc. | 2.586 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -231.79M |
| Total Expenses (Quarterly) | 231.79M |
| Enterprise Value | 13.12B |
| Earnings Yield | -6.92% |
| Normalized Earnings Yield | -6.922 |